FDA is set to announce new warning on J&J vaccine after 100 reports of it being linked to rare autoimmune disease Guillain-Barré syndrome
The FDA is planning to release a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease
Officials say there have been 100 reports of patients developing Guillain-Barré syndrome, a rare disorder that temporarily paralyzes parts of the body
Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older
Guillain-Barré is very rare after vaccination, occurring in just 0.000781% of patients who have received J&J's one-dose shot
The warning presents another setback for the company, which has been plagued by challenges including a pause due to rare blood clots and ingredient mix-ups
By Mary Kekatos Acting U.S. Health Editor For
Dailymail.ComPublished: 13:59 EDT, 12 July 2021 | Updated: 16:11 EDT, 12 July 2021
... Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older.
With just 100 cases reported out of 12.8 million doses administered, this means the condition is very rare occurring in just 0.000781 percent of cases.
The warning is yet another setback for J&J's vaccine, which has plagued by pauses, ingredient mix-ups and doses needing to be thrown out. ...